Krystal Biotech, Inc. Shares Outstanding (Cover Page)
Krystal Biotech, Inc. (KRYS) had Shares Outstanding (Cover Page) of 29.60 million shares as of 2026-07-28, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-03
- 2026-07-28: Entity Common Stock, Shares Outstanding 29.60M shares.
- 2026-04-29: Entity Common Stock, Shares Outstanding 29.48M shares.
- 2026-02-11: Entity Common Stock, Shares Outstanding 29.23M shares.
- 2025-10-29: Entity Common Stock, Shares Outstanding 29.00M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-28 | 29.60M shares 10-Q · filed 2026-08-03 |
| 2026-04-29 | 29.48M shares 10-Q · filed 2026-05-04 |
| 2026-02-11 | 29.23M shares 10-K · filed 2026-02-17 |
| 2025-10-29 | 29.00M shares 10-Q · filed 2025-11-03 |
| 2025-07-30 | 28.94M shares 10-Q · filed 2025-08-04 |
| 2025-05-01 | 28.90M shares 10-Q · filed 2025-05-06 |
| 2025-02-12 | 28.81M shares 10-K · filed 2025-02-19 |
| 2024-10-28 | 28.76M shares 10-Q · filed 2024-11-04 |
| 2024-07-29 | 28.73M shares 10-Q · filed 2024-08-05 |
| 2024-04-29 | 28.56M shares 10-Q · filed 2024-05-06 |
| 2024-02-19 | 28.29M shares 10-K · filed 2024-02-26 |
| 2023-10-30 | 28.21M shares 10-Q · filed 2023-11-06 |
| 2023-07-31 | 27.99M shares 10-Q · filed 2023-08-07 |
| 2023-05-01 | 25.80M shares 10-Q · filed 2023-05-08 |
| 2023-02-20 | 25.76M shares 10-K · filed 2023-02-27 |
| 2022-10-31 | 25.75M shares 10-Q · filed 2022-11-07 |
| 2022-07-29 | 25.66M shares 10-Q · filed 2022-08-08 |
| 2022-04-29 | 25.64M shares 10-Q · filed 2022-05-09 |
| 2022-02-18 | 25.21M shares 10-K · filed 2022-02-28 |
| 2021-10-29 | 22.24M shares 10-Q · filed 2021-11-08 |
| 2021-07-30 | 22.21M shares 10-Q · filed 2021-08-09 |
| 2021-04-30 | 22.20M shares 10-Q · filed 2021-05-10 |
| 2021-02-19 | 22.19M shares 10-K · filed 2021-03-01 |
| 2020-10-30 | 19.71M shares 10-Q · filed 2020-11-09 |
| 2020-07-31 | 19.66M shares 10-Q · filed 2020-08-07 |
| 2020-04-30 | 17.39M shares 10-Q · filed 2020-05-04 |
| 2020-02-28 | 17.36M shares 10-K · filed 2020-03-10 |
| 2019-10-31 | 17.31M shares 10-Q · filed 2019-11-04 |
| 2019-07-31 | 17.30M shares 10-Q · filed 2019-08-05 |
| 2019-04-30 | 14.44M shares 10-Q · filed 2019-05-07 |
| 2018-10-31 | 14.43M shares 10-Q · filed 2018-11-05 |
| 2018-07-31 | 10.35M shares 10-Q · filed 2018-08-06 |
| 2018-04-30 | 10.31M shares 10-Q · filed 2018-05-07 |
| 2018-02-28 | 10.31M shares 10-K · filed 2018-03-12 |
| 2017-10-31 | 10.24M shares 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |